MannKind Ownership | Who Owns MannKind?


OverviewForecastRevenueFinancialsChartTranscripts

MannKind Ownership Summary


MannKind is owned by 10.56% institutional investors, 1.64% insiders, and 87.80% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 9.44% of MNKD shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.97% of its assets in MannKind shares.

MNKD Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockMannKind10.56%1.64%87.80%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustryBiotech Stocks 381.47%10.55%-292.02%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de28.95M9.44%$164.14M
Blackrock22.56M8.34%$117.75M
Vanguard group17.88M5.83%$101.38M
State street10.74M3.52%$57.67M
Rubric capital management lp7.48M2.44%$42.39M
Geode capital management7.37M2.40%$41.82M
Nitorum capital6.56M2.15%$35.24M
Ubs group5.10M1.66%$28.93M
D. e. shaw4.27M1.55%$27.45M
Avoro capital advisors4.47M1.47%$24.00M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Nitorum capital6.56M6.19%$35.24M
Tsp capital management group2.96M4.11%$16.80M
180 wealth advisors2.96M1.91%$16.78M
1492 capital management535.27K1.16%$3.03M
Deltec asset management974.70K0.92%$5.53M
Eversept partners, lp2.04M0.76%$10.97M
Stonepine capital management157.57K0.69%$846.15K
Rubric capital management lp7.48M0.51%$42.39M
Scopia capital management lp694.96K0.47%$3.73M
Parkman healthcare partners656.08K0.37%$3.52M

Top Buyers

HolderShares% AssetsChange
Wellington management group llp3.47M0.00%2.63M
Millennium management3.45M0.01%1.80M
Adage capital partners gp1.69M0.01%1.69M
Eversept partners, lp2.04M0.76%1.35M
Voloridge investment management1.23M0.02%1.06M

Top Sellers

HolderShares% AssetsChange
Rubric capital management lp7.48M0.51%-3.94M
Two sigma advisers, lp1.83M0.02%-1.56M
Jpmorgan chase522.19K0.00%-1.53M
Connor, clark & lunn investment management---1.48M
Qube research2.60M0.01%-1.47M

New Positions

HolderShares% AssetsChangeValue
Adage capital partners gp1.69M0.01%1.69M$9.10M
Schroder investment management group485.09K0.00%485.09K$2.60B
Y-intercept (hong kong)238.68K0.03%238.68K$1.35M
Voleon capital management lp237.24K0.03%237.24K$1.27M
Diadema partners lp212.47K0.29%212.47K$1.14M

Sold Out

HolderChange
Mather group, llc.-4.00
Jpl wealth management-5.00
Tfc financial management-6.00
Geowealth management-9.00
Newbridge financial services group-10.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202572-70.12%32,410,285-81.24%100.33%35-66.98%15-80.77%
Sep 30, 202585-64.14%32,712,871-80.77%100.34%37-63.00%25-63.24%
Jun 30, 2025233-11.41%169,987,066-3.57%561.66%95-22.76%69-2.82%
Mar 31, 20252592.78%176,169,0934.99%581.56%120-8.40%7238.46%
Dec 31, 20242390.42%157,530,9152.06%571.82%119-0.83%533.92%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv9.15M2.97%-
Vanguard US Total Market Shares ETF8.09M2.66%-22.90K
State Street® SPDR® S&P® Biotech ETF7.76M2.52%-41.75K
iShares Russell 2000 ETF7.28M2.37%1.87M
Vanguard Institutional Extnd Mkt Idx Tr3.31M1.08%14.11K
Fidelity Select Biotechnology3.30M1.07%-
Fidelity Small Cap Index3.06M0.99%16.31K
SPDR® S&P Biotech ETF2.87M0.93%6.40K
iShares Russell 2000 Growth ETF2.52M0.82%744.42K
iShares Biotechnology ETF2.19M0.71%267.25K

Recent Insider Transactions


DateNameRoleActivityValue
Mar 10, 2026Castagna Michael Chief Executive OfficerBuy$259.00K
Jan 08, 2026Tross Stuart A Chief People & Workpl OfficerSell$297.55K
Dec 17, 2025Castagna Michael Chief Executive OfficerSell$395.48K
Dec 16, 2025Castagna Michael Chief Executive OfficerSell$127.86K
Dec 02, 2025Castagna Michael Chief Executive OfficerSell$601.11K

Insider Transactions Trends


DateBuySell
2026 Q111
2025 Q4-5
2025 Q3-3
2025 Q2-5
2025 Q1--

MNKD Ownership FAQ


Who Owns MannKind?

MannKind shareholders are primarily institutional investors at 10.56%, followed by 1.64% insiders and 87.80% retail investors. The average institutional ownership in MannKind's industry, Biotech Stocks , is 381.47%, which MannKind falls below.

Who owns the most shares of MannKind?

MannKind’s largest shareholders are Blackrock funding, inc. /de (28.95M shares, 9.44%), Blackrock (22.56M shares, 8.34%), and Vanguard group (17.88M shares, 5.83%). Together, they hold 23.61% of MannKind’s total shares outstanding.

Does Blackrock own MannKind?

Yes, BlackRock owns 8.34% of MannKind, totaling 22.56M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 117.75M$. In the last quarter, BlackRock increased its holdings by 931.32K shares, a 4.31% change.

Who is MannKind’s biggest shareholder by percentage of total assets invested?

Nitorum capital is MannKind’s biggest shareholder by percentage of total assets invested, with 6.19% of its assets in 6.56M MannKind shares, valued at 35.24M$.

Who is the top mutual fund holder of MannKind shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of MannKind shares, with 2.97% of its total shares outstanding invested in 9.15M MannKind shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools